Wed, Sep 11, 2024
The new injectable facility of Eugia Steriles, a subsidiary of Eugia Pharma Specialities and a stepdown unit of the company, situated at Anakapalli District of Andhra Pradesh was inspected by the US FDA from March 28 to April 5 this year.
More >
Fri, Aug 16, 2024
Aurobindo Pharma Ltd's subsidiary Eugia Pharma Specialities Ltd has received a warning letter from the USFDA for its Telangana-based formulation manufacturing unit. This follows the unit's earlier classification as 'Official Action Indicated' (OAI). Despite this, the company assures there is no impact on current US market supplies and remains committed to improving compliance with FDA regulations.
Mon, Jul 15, 2024
Why is Aurobindo Pharma in action? Board meeting on July 18, big decision possible. Know complete details from Nupur.
Tue, Apr 26, 2016
The company received approval from USFDA for a generic version of blood pressure treatment drugs
Fri, Apr 22, 2016
The company said the launch of the product is based on the settlement terms/litigation outcome with AstraZeneca.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
